Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Failure to Properly Label and Date Multi-Dose Insulin Pens

Dunmore, Pennsylvania Survey Completed on 12-03-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors observed that the facility failed to comply with accepted standards for labeling and storing multi-dose insulin pens on one of two medication carts inspected. Specifically, on the 1 East Hall medication cart, one multi-dose insulin pen of Insulin Aspart and three multi-dose insulin pens of Insulin Glargine were found to be opened and in use without documentation of the date opened or the expiration date. Manufacturer-provided labels on the pens, which included designated spaces for this information, were left blank. Additionally, one Insulin Glargine pen had a blank sticker affixed, indicating it was in use but not properly dated. A review of the facility's policy and the manufacturer's instructions confirmed that opened multi-dose insulin pens must be dated and discarded within 28 days unless otherwise specified. Interviews with an LPN and the Nursing Home Administrator confirmed that the pens were in use and not dated as required by both facility policy and manufacturer guidelines. The failure to document the date opened and expiration date for these medications constituted noncompliance with pharmacy service regulations and resident care policies.

An unhandled error has occurred. Reload 🗙